Syensqo SA/NV Logo

Syensqo SA/NV

ISIN: BE0974464977 | Ticker: SYENS | LEI: 549300060XNJ90PLNS10
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Belgium

About Syensqo SA/NV

Company Description

At Syensqo, we’re explorers: experts in science and passionate about all its possibilities. Our innovative products and solutions help enhance the way people around the world live life every day: how they work, travel, and spend leisure time.

Inspired by the legacy of the Solvay Congresses, which brought together the greatest scientific minds to explore answers to the world’s biggest challenges, we strive to break new ground: addressing the critical needs of today and creating solutions for the future. We’re constantly expanding on what’s seemingly impossible and pushing the limits of what can be realized.

With a diverse global team of more than 13,000 employees in 30 countries, we work together to advance science and help humanity move forward.

Year founded


Served area





Rue de la Fusee 98, 1130 Brussels – Belgium

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
24.05.24 van de Kerkhof Heike Board Buy EUR 35,597.80
24.05.24 Thorne Rosemary Board Buy EUR 18,780.18
10.04.24 Kadri Ilham Executive member Buy EUR 0.00
09.04.24 Roger Davis Christopher Executive member Buy EUR 0.00
28.03.24 Boxus Joëlle Executive member Buy EUR 0.00
27.03.24 Tiberghien Hervé Executive member Buy EUR 0.00
13.03.24 Rollinger Mark Executive member Buy EUR 50,155.58
25.01.24 Tiberghien Hervé Executive member Buy EUR 80,385.30
22.01.24 Roger Davis Christopher Executive member Buy EUR 100,147.73
19.01.24 Kadri Ilham Executive member Buy EUR 495,972.72

Capital markets information






Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

Euronext Brussels

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.